Literature DB >> 30928326

Expression of cornulin in oral premalignant lesions.

Neetha Santosh1, Kristin K McNamara2, F Michael Beck3, John R Kalmar4.   

Abstract

OBJECTIVE: The aim of this study was to evaluate expression of cornulin in oral mucosa as an adjunct to histopathologic grading of oral epithelial dysplasia (OED). STUDY
DESIGN: Biomarker expression was assessed in normal oral mucosa, low-grade OED (LD), high-grade OED (HD), and oral squamous cell carcinoma (OSCC) by using immunohistochemistry. Photomicrographs were evaluated with Aperio Imagescope using a positive-pixel-counting algorithm. A histo-score (H-score) was calculated on the basis of staining intensity and the percentage of positive cells (%-staining). Intrarater reliability for H-score and %-staining was determined by calculating interclass correlation coefficients. Mean differences in H-scores and %-percent staining values were each analyzed by using an analysis of variance and Tukey's post hoc procedure.
RESULTS: Cornulin expression progressively diminished with increasing grades of dysplasia and OSCC. Interclass correlation coefficients for H-score and %-staining were each greater than 0.99. Except for OSCC versus HD, all other pairwise comparisons were statistically significant (P < .0001) for H-score and %-staining.
CONCLUSIONS: Cornulin expression helped differentiate between low-grade and high-grade oral epithelial dysplasia, making it a potential adjunct for grading oral OEDs and a potential biomarker for risk of lesion progression. Longitudinal studies evaluating risk stratification based on cornulin expression may be warranted.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30928326     DOI: 10.1016/j.oooo.2019.02.003

Source DB:  PubMed          Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol


  6 in total

1.  Identification of Salivary Proteomic Biomarkers for Oral Cancer Screening.

Authors:  Shigeo Ishikawa; Kenichi Ishizawa; Atsushi Tanaka; Hirohito Kimura; Kenichiro Kitabatake; Ayako Sugano; Kaoru Edamatsu; Shohei Ueda; Mitsuyoshi Iino
Journal:  In Vivo       Date:  2021 Jan-Feb       Impact factor: 2.155

2.  High expression of both desmoplastic stroma and epithelial to mesenchymal transition markers associate with shorter survival in pancreatic ductal adenocarcinoma.

Authors:  Damián Sánchez-Ramírez; Rafael Medrano-Guzmán; Fernando Candanedo-González; Jazmín De Anda-González; Luis Enrique García-Rios; Vadim Pérez-Koldenkova; Marcos Gutiérrez-de la Barrera; Sara Rodríguez-Enríquez; Marco Velasco-Velázquez; Silvia Cecilia Pacheco-Velázquez; Patricia Piña-Sánchez; Héctor Mayani; Alejandro Gómez-Delgado; Alberto Monroy-García; Ana Karen Martínez-Lara; Juan José Montesinos
Journal:  Eur J Histochem       Date:  2022-02-17       Impact factor: 3.188

3.  Prognostic Value of GPNMB, EGFR, p-PI3K, and Ki-67 in Patients with Esophageal Squamous Cell Carcinoma.

Authors:  Bo Wang; Mengyan Li; Anna Su; Yongmei Gao; Yan Shi; Chao Li; Wenying Liu; Liping Su; Wan Li; Yuqing Ma
Journal:  Anal Cell Pathol (Amst)       Date:  2022-08-31       Impact factor: 4.133

4.  Revisiting vimentin: a negative surrogate marker of molecularly defined oligodendroglioma in adult type diffuse glioma.

Authors:  Seong-Ik Kim; Kwanghoon Lee; Jeongmo Bae; Sungyoung Lee; Hongseok Yun; Chul-Kee Park; Seung Hong Choi; Christopher Alec Maquiling; Sung-Hye Park; Jae-Kyung Won
Journal:  Brain Tumor Pathol       Date:  2021-08-02       Impact factor: 3.298

5.  Involvement of CHP2 in the Development of Non-Small Cell Lung Cancer and Patients' Poor Prognosis.

Authors:  Liqin Xu; Yanmei Qin; Baier Sun; Haiying Wang; Jun Gu; Zhiyuan Tang; Weishuai Zhang; Jian Feng
Journal:  Appl Immunohistochem Mol Morphol       Date:  2020-10

6.  The integration of differentially expressed genes based on multiple microarray datasets for prediction of the prognosis in oral squamous cell carcinoma.

Authors:  Yinuan Zhao; Jiacheng Huang; Jianzhi Chen
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.